BRD4-targeted Therapy Induces Myc-Independent Cytotoxicity in Gnaq/11-Mutatant Uveal Melanoma Cells

Oncotarget - United States
doi 10.18632/oncotarget.5179
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

FAK Is a Critical Mediator of GNAQ-Driven Uveal Melanoma

Cancer Discovery
Oncology
2019English

Culturing Uveal Melanoma Cells

Ocular Oncology and Pathology
Nursing
2015English

Evolving Systemic Targeted Therapy Strategies in Uveal Melanoma and Implications for Ophthalmic Management: A Review

Clinical and Experimental Ophthalmology
MedicineOphthalmology
2016English

Proton Therapy for Uveal Melanoma in 43 Juvenile Patients

Ophthalmology
Ophthalmology
2014English

HER2 as a Promising Target for Cytotoxicity T Cells in Human Melanoma Therapy

PLoS ONE
Multidisciplinary
2013English

Prognosis in Uveal Melanoma

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1948English

Presence and Phenotype of Dendritic Cells in Uveal Melanoma

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2007English

Rechallenge of Targeted Therapy in Metastatic Melanoma

JDDG - Journal of the German Society of Dermatology
Dermatology
2019English

Bromodomain Containing 2 (BRD2); BRD3; BRD4; C-Myc (MYC)

Science-Business eXchange
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy